
MAKO Surgical
Founded Year
1997Stage
Acq - P2P | AcquiredTotal Raised
$57.01MValuation
$0000Revenue
$0000About MAKO Surgical
MAKO Surgical Corp. is a medical device company that markets its RIO Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and RESTORIS implants for orthopedic procedures called MAKOplasty. The RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, which enables precise, consistently reproducible bone resection for the accurate insertion and alignment of MAKO's RESTORIS implants. The MAKOplasty solution incorporates technologies enabled by an intellectual property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent applications.
Expert Collections containing MAKO Surgical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MAKO Surgical is included in 1 Expert Collection, including Robotics.
Robotics
1,974 items
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
MAKO Surgical Patents
MAKO Surgical has filed 424 patents.
The 3 most popular patent topics include:
- Surgery
- Orthopedic surgical procedures
- Surgical instruments

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
12/13/2019 | 8/29/2023 | Surgery, Orthopedic surgical procedures, Health informatics, Implants (medicine), Surgical procedures and techniques | Grant |
Application Date | 12/13/2019 |
---|---|
Grant Date | 8/29/2023 |
Title | |
Related Topics | Surgery, Orthopedic surgical procedures, Health informatics, Implants (medicine), Surgical procedures and techniques |
Status | Grant |
Latest MAKO Surgical News
Jun 12, 2023
Robotics Business Review April 5, 2016 The system will be released in early 2015, after Barrett achieves full FDA compliance for this 510(k)-exempt device. Barrett Medical will be a fresh spin-off from Barrett Technology Inc., which designed Proficio for DARPA to help returning veterans recovering from traumatic brain injury (TBI). The rehabilitation prescribed for TBI and stroke are virtually identical in their approach to these brain traumas. Barrett Technology’s flagship product, the WAM arm is listed in the special Millennium Edition of the Guinness Book of Records as being the world’s most advanced robotic arm for its ability to interact directly with humans through subtle force interactions. The WAM uses unique gearless transmissions that offer extraordinarily high fidelity force control. Underlining the value of these drives, Barrett licensed them to Mako Surgical for its highly-successful FDA-approved surgical robot. The WAM human-interactive robotic arm also leverages Barrett’s Puck servomotor controllers, which are protected by three issued patents and enable the user to experience exceptionally smooth forces. Barrett Technology will license all of the technology and knowhow required to manufacture Proficio. Barrett collaborates closely with the Rehabilitation Institute of Chicago, Spaulding Rehabilitation Hospital, and Braintree Rehabilitation Hospital, and we are grateful for the input from these institutions that helped shape Proficio. Company Leadership Startup Information Problem Your Company/Products Solve Every 40 seconds someone dies from stroke in the United States alone, according to the CDC. That’s 800,000 people per year. Of the survivors, at least half urgently need rehabilitation, since the sooner (and degree of) rehabilitation after a stroke (during the 6-month acute phase) the better the outcome. Proficio does not replace physical or occupational therapists. Instead, it leverages the capabilities of the PT, enabling engaging game-oriented rehabilitation that encourages longer and more frequent therapy sessions, and with less therapist fatigue. At the same time, Proficio collects data in ways that a therapists cannot, including information not only recording motions, but also recording the forces applied during those motions. The system is connected to a backend database that both the therapist and the patient can use to judge the rate of improvement. Data is kept in accordance with HIPAA rules that protects patients’ identities but can be used in the aggregate to begin to establish benchmarks for particular games. Use of these benchmarks and the data in general will build a competitive advantage for Barrett Medical. Barrett is not the first to market. The biggest competitor, Interactive Motion Technologies (IMT) makes the InMotion robotic rehabilitation device, but this device is limited to horizontal, planar motions. A special attachment is available for small vertical motions, but the benefit is marginal. Proficio has been designed from the ground up as a fundamentally 3D device, accommodating nearly every possible human reaching motion with equal ease. Humans move naturally in 3D and are not designed to operate while fixed to a plane. Market
MAKO Surgical Frequently Asked Questions (FAQ)
When was MAKO Surgical founded?
MAKO Surgical was founded in 1997.
Where is MAKO Surgical's headquarters?
MAKO Surgical's headquarters is located at 2555 Davie Road, Fort Lauderdale.
What is MAKO Surgical's latest funding round?
MAKO Surgical's latest funding round is Acq - P2P.
How much did MAKO Surgical raise?
MAKO Surgical raised a total of $57.01M.
Who are the investors of MAKO Surgical?
Investors of MAKO Surgical include Stryker, Sycamore Ventures, Ivy Capital Partners, Aperture Venture Partners, Lumira Ventures and 8 more.
Who are MAKO Surgical's competitors?
Competitors of MAKO Surgical include Digital Surgery Systems, Apollo Endosurgery, Activ Surgical, Tepha, Wright Medical Group, Celonova Biosciences, LifeBond, Intellirod Spine, Paragon Medical, RF Surgical Systems and 32 more.
Compare MAKO Surgical to Competitors

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.
ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures
Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.
Verimetra aims to make medical instruments "smart" and manufacturers miniature thin film sensors used in medical applications that involve very small high end catheters. The Company designs and manufactures sensors using micro-electromechanical systems (MEMS) technology, which is the only method available that produces sensors small enough to be embedded in surgical devices without changing their basic form or function, allowing the company's customers to sell the same products, now "smart", without requiring the surgeon to use a new device. Verimetra aims to make medical devices "smart" by embedding (US Patent 6,494,882) a variety of small sensors at an place on or within the device. Simply stated, the company make "dumb" metal tools "smart". Examples include forceps, grippers, retractors, drills, and other surgical devices. Through the use of Verimetra's products, medical device manufacturers are able to deliver features and functionality that, depending on the medical procedure, improve outcomes, reduce risk and shorten patient recovery times. Verimetra's new product features are also used by manufacturers to strengthen their market position, enter new markets and maintain gross margins. Verimetra aims to give these manufacturers a way to accomplish these goals by adding features at a low cost without product redesign. Furthermore, in many instances, Verimetra's customers' goals will be met by the transformation of a re-usable product (one-time sale) into a smart disposable product (one sale per procedure).